RIGEL PHARMACEUTICALS INC — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Kotzin Brian L. | — | Award / Grant | 25,000 | — | — | 50,000 | May 20, 2022 |
| Schorno Dean L | EVP &Chief Financial Officer | Award / Grant | 50,000 | — | — | 128,908 | Jan 24, 2022 |
| Dummer Wolfgang | EVP & CMO | Award / Grant | 50,000 | — | — | 67,848 | Jan 24, 2022 |
| Santos David A | EVP, Chief Commercial Officer | Award / Grant | 50,000 | — | — | 60,000 | Jan 24, 2022 |
| RODRIGUEZ RAUL R | CEO, President | Award / Grant | 200,000 | — | — | 391,776 | Jan 24, 2022 |
| VANCE DOLLY | EVP Corp. Affairs, G.C., Sect. | Award / Grant | 50,000 | — | — | 60,260 | Jan 24, 2022 |
| HANNAH ALISON L. | — | Award / Grant | 6,250 | — | — | 6,250 | May 19, 2021 |
| Goodwin Bradford S | — | Award / Grant | 25,000 | — | — | 35,000 | May 19, 2021 |
| MOOS WALTER H | — | Award / Grant | 25,000 | — | — | 27,222 | May 19, 2021 |
| Wasman Jane | — | Award / Grant | 25,000 | — | — | 25,000 | May 19, 2021 |
| Kotzin Brian L. | — | Award / Grant | 25,000 | — | — | 25,000 | May 19, 2021 |
| Katkin Keith | — | Award / Grant | 25,000 | — | — | 25,000 | May 19, 2021 |
| LAPOINTE ANTHONY GREGG | — | Award / Grant | 25,000 | — | — | 25,000 | May 19, 2021 |
| LYONS GARY A | — | Award / Grant | 25,000 | — | — | 25,000 | May 19, 2021 |
| Schorno Dean L | EVP &Chief Financial Officer | Purchase | 3,274 | $2.13 | $6,974 | 50,000 | May 22, 2019 |
| Cabatuan Nelson | Principal Accounting Officer | Sale | 10,000 | $3.12 | $31,200 | 58 | Oct 12, 2018 |
| Duliege Anne-Marie | EVP & Chief Medical Officer | Sale | 115,500 | $3.50 | $404,250 | — | Sep 17, 2018 |
| Mayer Eldon C. III | EVP & Chief Commercial Officer | Purchase | 50,000 | $3.28 | $164,000 | 165,000 | Sep 11, 2018 |
| Duliege Anne-Marie | EVP & Chief Medical Officer | Option Exercise | 16,500 | $2.54 | $41,910 | 16,500 | Sep 4, 2018 |
| Mayer Eldon C. III | EVP & Chief Commercial Officer | Purchase | 100,000 | $2.82 | $282,000 | 115,000 | Aug 23, 2018 |
| RODRIGUEZ RAUL R | CEO, President | Purchase | 114,000 | $2.63 | $299,820 | 173,519 | Aug 17, 2018 |
| Duliege Anne-Marie | EVP & Chief Medical Officer | Sale | 5,000 | $2.79 | $13,950 | — | Jul 2, 2018 |
| Duliege Anne-Marie | EVP & Chief Medical Officer | Sale | 5,000 | $4.11 | $20,550 | — | Apr 20, 2018 |
| Maynard Ryan D | EVP & CFO | Option Exercise | 100,000 | $2.14 | $214,000 | 100,000 | Nov 3, 2017 |
| Duliege Anne-Marie | Chief Medical Officer | Sale | 5,000 | $2.69 | $13,450 | — | Jul 5, 2017 |
| Duliege Anne-Marie | Chief Medical Officer | Sale | 5,000 | $2.41 | $12,050 | — | Jan 3, 2017 |
| PAYAN DONALD G | EVP, Pres. Discovery&Research | Sale | 5,303 | $4.00 | $21,212 | 53,031 | Aug 30, 2016 |
| PAYAN DONALD G | EVP, Pres. Discovery&Research | Sale | 41,666 | $3.68 | $153,331 | 58,334 | Jun 10, 2015 |
| PAYAN DONALD G | EVP, Pres. Discovery&Research | Sale | 10,000 | $3.75 | $37,500 | 58,334 | Apr 1, 2015 |
| VANCE DOLLY | EVP Corp. Affairs, G.C., Sect. | Sale | 1,000 | $2.22 | $2,220 | 575 | Dec 18, 2014 |
| VANCE DOLLY | EVP Corp. Affairs, G.C., Sect. | Sale | 1,000 | $2.22 | $2,220 | 575 | Dec 18, 2014 |
| PAYAN DONALD G | EVP, Pres. Discovery&Research | Sale | 20,000 | $2.56 | $51,200 | 68,334 | Sep 3, 2014 |
| PAYAN DONALD G | EVP, Pres. Discovery&Research | Sale | 20,000 | $3.71 | $74,200 | 88,334 | Feb 24, 2014 |
| BVF INC/IL | — | Sale | 153,056 | $2.64 | $404,068 | 646,559 | Nov 19, 2013 |
| LAMPERT MARK N | — | Purchase | 24,598 | $3.47 | $85,355 | 1,455,414 | Jun 7, 2013 |
| VANCE DOLLY | EVP Corp. Affairs, G.C., Sect. | Sale | 4,151 | $10.43 | $43,295 | 1,103 | Sep 13, 2012 |
| Maynard Ryan D | EVP & CFO | Option Exercise | 23,302 | $6.49 | $151,230 | 23,302 | Sep 12, 2012 |
| Maynard Ryan D | EVP & CFO | Option Exercise | 23,302 | $6.49 | $151,230 | 23,302 | Sep 7, 2012 |
| Maynard Ryan D | EVP & CFO | Sale | 17,586 | $10.52 | $185,005 | — | Sep 7, 2012 |
| Maynard Ryan D | EVP & CFO | Sale | 300 | $10.63 | $3,189 | — | Aug 7, 2012 |
| PAYAN DONALD G | EVP, Pres. Discovery&Research | Sale | 100 | $8.71 | $871 | 108,334 | Jun 19, 2012 |
| DEERFIELD PARTNERS, LP | — | Purchase | 46,524 | $8.00 | $372,192 | 470,425 | May 26, 2011 |
| DEERFIELD INTERNATIONAL LTD | — | Sale | 3,690 | $7.55 | $27,860 | 2,902,743 | Nov 3, 2010 |
| PAYAN DONALD G | EVP, Pres. Discovery&Research | Option Exercise | 3,334 | $1.80 | $6,001 | 118,334 | Jan 2, 2009 |
| Goodwin Bradford S | — | Purchase | 800 | $9.85 | $7,880 | 1,800 | Aug 9, 2007 |
| MOOS WALTER H | — | Option Exercise | 2,222 | $1.80 | $4,000 | 2,222 | Jun 26, 2007 |
| Grossbard Elliott B | Sr. VP Medical Development | Purchase | 2,000 | $9.68 | $19,360 | 2,000 | May 29, 2007 |
| FRAZIER ALAN D | — | Gift | 10,905 | — | — | — | Nov 28, 2005 |
| GOWER JAMES M | CEO & Board Chairman | Option Exercise | 50,000 | $1.80 | $90,000 | 180,676 | Nov 2, 2005 |